SCHEMBL12634201

SCHEMBL12634201

CCCCCC1CCC(c2ccc(-c3ccc(C(=O)Nc4ccc(-c5cc(-c6ccc(NC(C)=O)cc6)c6c(c5)-c5c(c7c(c8cc(C(F)(F)F)ccc58)OC(c5ccc(OC)cc5)(c5ccc(OC)cc5)C=C7)C6(C)C)cc4)cc3)cc2)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
PLAT P00750 1/20 0.34
MGAT2 Q10469 2/20 0.32
CCR2 P41597 1/20 0.32
KCNH2 Q12809 1/20 0.32
P2RY14 Q15391 1/20 0.32
DGAT1 O75907 1/20 0.32
MAPK14 Q16539 1/20 0.31
MEN1 O00255 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
RAF1 P04049 1/20 0.31
BRAF P15056 1/20 0.31
GCGR P47871 1/20 0.31
GIPR P48546 1/20 0.31
SMO Q99835 1/20 0.31
MCHR1 Q99705 3/20 0.31
MTTP P55157 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1333590 0.98 PLG (0.35) PLGPLAUPLATMGAT2CCR2
SCHEMBL29910223 0.98 PLG (0.35) PLGPLAUPLATMGAT2CCR2
SCHEMBL12573714 0.94 PLG (0.34) PLGPLAUPLATMGAT2CCR2
SCHEMBL1334049 0.94 PLG (0.34) PLGPLAUPLATMGAT2CCR2
SCHEMBL29910200 0.94 PLG (0.34) PLGPLAUPLATMGAT2CCR2
SCHEMBL1334027 0.93 PLG (0.36) PLGPLAUPLATMGAT2CCR2
SCHEMBL29910266 0.93 PLG (0.36) PLGPLAUPLATMGAT2CCR2
SCHEMBL2016514 0.91 MCHR1 (0.35) PLGPLAUPLATMGAT2CCR2
SCHEMBL30914182 0.91 PLG (0.36) PLGPLAUPLATMGAT2CCR2
SCHEMBL1334077 0.91 MCHR1 (0.35) PLGPLAUPLATMGAT2CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8545984-B2 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2013-10-01 US disclosed
US-20110129678-A1 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110129678-A1 Photochromic compounds and compositions CRY2, CRY1, PPOX PLG 2275/4885PLAU 4632/4885PLAT 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.